Back

Rural Disadvantage in Glioblastoma Concentrates in the Early Postoperative Period: A Single-Center, Treatment-Standardized Cohort Study

2026-01-08 health systems and quality improvement Title + abstract only
View on medRxiv
Show abstract

BackgroundGlioblastoma (GB) is the most common and most aggressive malignant primary brain tumor, with 5-year survival rates around 5%. While treatment-related factors significantly impact outcomes, the influence of sociodemographic variables remains unclear, with prior studies showing inconsistent findings. These inconsistencies may stem from underrepresentation of rural patients within national databases and from comparison across centers with variable treatment practices. ObjectiveTo evaluat...

Predicted journal destinations